Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Inventory Average (2021 - 2025)

GeneDx Holdings (WGS) has disclosed Inventory Average for 5 consecutive years, with $12.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory Average rose 14.47% to $12.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.3 million, a 14.47% increase, with the full-year FY2025 number at $12.3 million, up 26.63% from a year prior.
  • Inventory Average was $12.3 million for Q4 2025 at GeneDx Holdings, up from $11.3 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $42.9 million in Q3 2022 to a low of $9.1 million in Q4 2023.
  • A 5-year average of $20.1 million and a median of $12.3 million in 2025 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: skyrocketed 42.24% in 2022, then tumbled 75.66% in 2023.
  • GeneDx Holdings' Inventory Average stood at $32.3 million in 2021, then decreased by 10.51% to $28.9 million in 2022, then plummeted by 68.66% to $9.1 million in 2023, then rose by 18.17% to $10.7 million in 2024, then rose by 14.47% to $12.3 million in 2025.
  • Per Business Quant, the three most recent readings for WGS's Inventory Average are $12.3 million (Q4 2025), $11.3 million (Q3 2025), and $12.3 million (Q2 2025).